CVS Health Corp. Hits New 52-Week High of $110.62

CVS Health Corp. has reached a significant milestone by hitting a new 52-week high of USD 110.62 on July 21, 2026. This achievement underscores the company's strong performance in the retailing sector, particularly as it has demonstrated an impressive one-year performance of 83.48%, significantly outpacing the S&P 500's 19.09% return during the same period. With a market capitalization of USD 118,730 million, CVS Health Corp. is classified as a large-cap company. The stock's price-to-earnings (P/E) ratio stands at 13.00, indicating a favorable valuation relative to its earnings. Additionally, the company offers a dividend yield of 2.83%, appealing to income-focused investors. CVS Health Corp. maintains a debt-to-equity ratio of 0.72, reflecting a balanced approach to leveraging, while its return on equity is reported at 12.13%, showcasing effective management of shareholder equity. The stock's price-to-book ratio is 1.58, further illustrating its valuation metrics. Overall, CVS Health Corp.'s recent performance highlights its robust position within the retailing industry.